Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06357221
Status:
COMPLETED
Last Update Posted:
2024-06-03
First Post:
2024-03-20
Brief Title:
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
Sponsor:
Galderma RD
Organization:
Galderma RD
Study Overview
Official Title:
A Multi-center Open-label In-use Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Subjects having mild-to-severe plaque psoriasis with active target lesion plaques and currently on or starting a prescription treatment for plaque psoriasis will apply a topical skincare regimen to one side of the body Evaluations of the regimens efficacy will be conducted at 2 weeks 4 weeks and 8 weeks post-baseline
Detailed Description:
This is a multi-center open-label in-use study Adult subjects having mild-to-severe plaque psoriasis with active target lesion plaques and currently on or starting a prescription treatment for plaque psoriasis will be recruited for participation in the study
Subjects will report to the site at Baseline day 0 visit will be given an informed consent form HIPAA form photography release form and medical history form to complete
Subjects will be screened on the basis of the selection criteria for study qualification Eligible subjects will be assessed at Baseline visit and instructed to start applying the skincare products to the assigned side of the body based on the pre-determined randomization
Subjects to return to the site at Week 2 3 days Week 4 5 days and Week 8 5 days for follow-ups
Subjects will report to the site at Baseline day 0 visit will be given an informed consent form HIPAA form photography release form and medical history form to complete
Subjects will be screened on the basis of the selection criteria for study qualification Eligible subjects will be assessed at Baseline visit and instructed to start applying the skincare products to the assigned side of the body based on the pre-determined randomization
Subjects to return to the site at Week 2 3 days Week 4 5 days and Week 8 5 days for follow-ups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None